Skip to content

Clinical trials

Phase 3 Hidradenitis Suppurativa trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hidradenitis Suppurativa Phase: Phase 3 Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20192
20203
20211
20221
20233
20245
20257
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting9
Recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation6
Novartis Pharmaceuticals6
MoonLake Immunotherapeutics AG4
UCB Biopharma SRL4
AbbVie2
ACELYRIN Inc.1
University of California, Davis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hidradenitis Suppurativa24
Hidradenitis10
Skin Diseases6
Skin Diseases, Bacterial4
Suppuration4
Sweat Gland Diseases4
Dermatitis2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.